Malaysian Genomics Reports RM28.36 Million Full-Year Revenue Aug 30, 2022 14:00 HKT | ![Malaysian](http://www.acnnewswire.com/images/toppage/MalaysianGenomics60.jpg) |
|
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results Aug 29, 2022 18:30 HKT | ![Suzhou](http://www.acnnewswire.com/images/toppage/BaseCare_Top.jpg) |
|
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022 Aug 29, 2022 18:00 HKT | ![Avance](http://www.acnnewswire.com/images/toppage/AvanceClinical25.jpg) |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region Aug 29, 2022 14:00 HKT | ![Malaysian](http://www.acnnewswire.com/images/toppage/MalaysianGenomics60.jpg) |
|
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma Aug 29, 2022 12:46 HKT | |
|
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases Aug 26, 2022 20:15 HKT | |
|
Zhaoke Ophthalmology Announces 2022 Interim Results Aug 24, 2022 20:37 HKT | ![Zhaoke](http://www.acnnewswire.com/images/toppage/Zhaoke_Top.jpg) |
|
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA Aug 24, 2022 08:05 HKT | ![SinoMab](http://www.acnnewswire.com/images/toppage/SinoMab_Top.jpg) |
|
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore Aug 24, 2022 07:55 HKT | ![Avantor](http://www.acnnewswire.com/images/toppage/avantor.logo.68.jpg) |
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease Aug 23, 2022 20:37 HKT | ![Oculis](http://www.acnnewswire.com/images/toppage/Oculis_Top.jpg) |
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion Aug 23, 2022 19:51 HKT | ![Sino](http://www.acnnewswire.com/images/toppage/SinoBio_Top.jpg) |
|
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes Aug 22, 2022 09:47 HKT | |
|
Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume Aug 22, 2022 09:29 HKT | ![Peijia](http://www.acnnewswire.com/images/toppage/Peijia.64.jpg) |
|
IVD Medical Announces 2022 Interim Results Aug 22, 2022 07:30 HKT | ![IVD](http://www.acnnewswire.com/images/toppage/iVD52.jpg) |
|
New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82% Aug 19, 2022 19:51 HKT | ![New](http://www.acnnewswire.com/images/toppage/NewHorizon1_Top.jpg) |
|
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY Aug 19, 2022 17:55 HKT | ![Legend](http://www.acnnewswire.com/images/toppage/LegendCapital_Top.jpg) |
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022 Aug 19, 2022 14:00 HKT | ![Taiwan](http://www.acnnewswire.com/images/toppage/TaiwanExcellence25.jpg) |
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022 Aug 19, 2022 14:00 HKT | ![Taiwan](http://www.acnnewswire.com/images/toppage/TaiwanExcellence25.jpg) |
|
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ Aug 19, 2022 11:30 HKT | |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU Aug 18, 2022 18:00 HKT | ![Malaysian](http://www.acnnewswire.com/images/toppage/MalaysianGenomics60.jpg) |
|